0001209191-23-015668.txt : 20230303 0001209191-23-015668.hdr.sgml : 20230303 20230303170024 ACCESSION NUMBER: 0001209191-23-015668 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moore Mary Ann E CENTRAL INDEX KEY: 0001894731 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 23705368 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pediatrix Medical Group, Inc. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: MEDNAX, INC. DATE OF NAME CHANGE: 20090102 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-01 0 0000893949 Pediatrix Medical Group, Inc. MD 0001894731 Moore Mary Ann E 1301 CONCORD TERRACE SUNRISE FL 33323 0 1 0 0 EVP, General Counsel & Sec Common Stock 16880 I By Trust Common Stock 2023-03-01 4 A 0 55664 0.00 A 84700 D Common Stock 2023-03-01 4 F 0 2345 15.74 D 82355 D The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein. Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan. Excludes 16,340 previously reported shares of restricted common stock granted to the reporting person pursuant to the Plan in connection with an annual equity award that were forfeited because the performance-based criteria were not achieved. Represents 2,345 restricted shares withheld for payment of taxes upon vesting of shares. /s/ Mary Ann E. Moore 2023-03-03